Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

35.89 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Where Will Moderna Be in 10 Years? ↗

July 05, 2025

Via The Motley Fool

Why Moderna Stock Was So Healthy This Week ↗

July 04, 2025

Via The Motley Fool

RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval ↗

July 03, 2025

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid concerns about rare side effects.

Via Benzinga

CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panel ↗

July 02, 2025

The agency expanded its RSV and meningococcal vaccine guidance to cover younger age groups and new formulations.

Via Stocktwits

Topics Government

Which S&P500 stocks are moving on Wednesday? ↗

July 02, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 02, 2025

Via Benzinga

RFK Jr. Just Did The Unexpected. He Helped Moderna. ↗

July 02, 2025

The new Health Secretary reportedly recommended Moderna's RSV vaccine for a broader group of adults.

Via Investor's Business Daily

Explore the top gainers and losers within the S&P500 index in today's session. ↗

July 02, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

Tuesday's session: top gainers and losers in the S&P500 index ↗

July 01, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Via Chartmill

Got $200? 2 Biotech Stocks to Buy and Hold Forever ↗

July 01, 2025

Via The Motley Fool

Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability? ↗

June 30, 2025

Shares have long struggled, but things could be looking up for Moderna stock in the face of new flu shot results.

Via Investor's Business Daily

Moderna's mRNA Flu Vaccine Outperforms Standard Shots ↗

June 30, 2025

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase 3 study.

Via Benzinga

What's going on in today's pre-market session: S&P500 movers ↗

June 30, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial ↗

June 30, 2025

The data is key to receiving approvals for both the individual vaccine candidate and the company’s seasonal flu-COVID combination vaccine candidate.

Via Stocktwits

Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

June 30, 2025

Via ACCESS Newswire

CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm ↗

June 26, 2025

The panel also voted to recommend Merck’s RSV antibody drug Enflonsia for newborns whose mothers didn’t receive prenatal protection.

Via Stocktwits

RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group ↗

June 26, 2025

Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts.

Via Benzinga

Moderna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine Skeptics ↗

June 25, 2025

RFK Jr.'s newly appointed CDC panel, half of whom oppose vaccines, prepares to review key data on COVID, RSV, and flu shots.

Via Stocktwits

Uncover the latest developments among S&P500 stocks in today's session. ↗

June 24, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

1 Volatile Stock with Impressive Fundamentals and 2 to Be Wary Of

June 20, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine ↗

June 17, 2025

Via Benzinga

Topics Artificial Intelligence Initial Public Offering

Robert F. Kennedy Jr.'s CDC Overhaul 'Critically Weakened' US Vaccine Program, Say Ousted Experts ↗

June 17, 2025

Fired vaccine experts warn that Health Secretary Robert F. Kennedy Jr.'s overhaul of the CDC's key vaccine advisory panel threatens public health and undermines decades of immunization progress,...

Via Benzinga

Top S&P500 movers in Monday's session ↗

June 16, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

Monday's session: top gainers and losers in the S&P500 index ↗

June 16, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Which S&P500 stocks are gapping on Monday? ↗

June 16, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up ↗

June 13, 2025

The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.

Via Benzinga

Moderna’s RSV Vaccine Gets FDA Nod For Younger At-Risk Adults: Retail Stays Guarded Amid RFK Jr’s Immunization Shake-Up ↗

June 13, 2025

The company plans to make mRESVIA available for both younger and older adults in the U.S. ahead of the 2025-2026 respiratory virus season.

Via Stocktwits

Topics Government

3 Healthcare Stocks with Questionable Fundamentals

June 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

June 12, 2025

Via ACCESS Newswire

Exploring the top movers within the S&P500 index during today's session. ↗

June 12, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.